hotspot -WSS

hotspot

author：hotspot 2025-10-01 15:31:08 - browse：89

Illustration: Alex Hogan/STAT; Photo: Courtesy Perrigo

It’s not every day that a marketing team is tasked with designing the branding and packaging of the first over-the-counter birth control pill to be sold in the U.S.

This was the challenge, and the opportunity, faced by the team behind Opill, the landmark pill from drugmaker Perrigo that received approval from the Food and Drug Administration earlier this month. Their brief: Create a design that would stand out in America’s notoriously sprawling pharmacy aisles; inspire trust and confidence; be easy to remember and recognize; appeal to women — including teenagers — as well as trans men and nonbinary people; clearly communicate its purpose; be simple to carry and use; contain straightforward but accurate user information; and clear FDA requirements.

Settling on the right approach took years of research and testing, which resulted in the name Opill and packaging featuring bright teal, saturated pink, and yellow, as well as a rounded font reminiscent of millennials’ ubiquitous favorite Gotham. All of these features are intended to set the product apart from the dozens of prescription contraceptive pills available in the U.S. market and internationally.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： STAT Summit: How researchers deal with rejection

focus

explore

WSS

Element Biosciences CEO lays out genome sequencing strategy

Why rehabilitation engineers need to center patients in their research

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

More tobacco lobbyists active in statehouses

How AI can help patients find reliable information about doctors

Exact Sciences stock tumbles despite strong cancer detection sales

entertainment

hotspot

leisure time

What does generative AI mean for health care? We asked experts

Element Biosciences CEO lays out genome sequencing strategy

In age of alternative facts, a scholarly course on calling out crap

Is there really a nursing shortage in the U.S.?

BioMarin wins approval for gene therapy to treat hemophilia A

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

BioMarin wins approval for gene therapy to treat hemophilia A

Bird flu outbreak in cows is latest avian flu curveball

The high cost of giving birth even with insurance

STAT Readout: Friday, Oct. 20 biotech updates

leisure time

Cancer researcher Catriona Jamieson is sending tumors into space

Close Medicare's dangerous gaps in addiction treatment coverage

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

How AI can help patients find reliable information about doctors

Is there really a nursing shortage in the U.S.?

Roche acquires Telavant from Roivant, adding experimental IBD treatment

focus

focus

explore

hotspot